These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2404183)

  • 1. Evolution of the concept of proctosigmoiditis: clinical observation.
    Farmer RG
    Med Clin North Am; 1990 Jan; 74(1):91-102. PubMed ID: 2404183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis for patients with ulcerative proctosigmoiditis (ulcerative colitis confirmed to the rectum and sigmoid colon).
    Farmer RG
    J Clin Gastroenterol; 1979 Mar; 1(1):47-50. PubMed ID: 263130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.
    Sutherland LR; Martin F; Greer S; Robinson M; Greenberger N; Saibil F; Martin T; Sparr J; Prokipchuk E; Borgen L
    Gastroenterology; 1987 Jun; 92(6):1894-8. PubMed ID: 3569765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diversion colitis in Crohn disease. A case report and review of the literature].
    Löhr HF; Mayet WJ; Singe CC; Ramadori G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1989 Apr; 27(4):221-4. PubMed ID: 2658397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of ulcerative proctitis, proctosigmoiditis, and left-sided colitis.
    Bitton A
    Semin Gastrointest Dis; 2001 Oct; 12(4):263-74. PubMed ID: 11726080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course and prognosis of idiopathic ulcerative proctosigmoiditis in young patients.
    Mir-Madjlessi SH; Michener WM; Farmer RG
    J Pediatr Gastroenterol Nutr; 1986; 5(4):571-5. PubMed ID: 2874204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-aminosalicylic acid enema (Pentasa) versus hydrocortisone acetate foam (Proctocort) for the treatment of outbreaks of proctitis and cryptogenetic proctosigmoiditis. A comparative randomized multicenter trial].
    Ngô Y; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(6-7):558-63. PubMed ID: 1526418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natural history of intestinal lesions in inflammatory bowel disease].
    Beaugerie L
    Rev Prat; 2014 Nov; 64(9):1226-9. PubMed ID: 25638859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis.
    Sandborn WJ; Bosworth B; Zakko S; Gordon GL; Clemmons DR; Golden PL; Rolleri RL; Yu J; Barrett AC; Bortey E; Paterson C; Forbes WP
    Gastroenterology; 2015 Apr; 148(4):740-750.e2. PubMed ID: 25644096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
    Frühmorgen P; Demling L
    Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New therapeutic goals in inflammatory bowel diseases].
    Vuitton L; Peyrin-Biroulet L
    Rev Prat; 2014 Nov; 64(9):1232-6. PubMed ID: 25638861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.
    Gross V; Bar-Meir S; Lavy A; Mickisch O; Tulassay Z; Pronai L; Kupcinskas L; Kiudelis G; Pokrotnieks J; Kovács A; Faszczyk M; Razbadauskas A; Margus B; Stolte M; Müller R; Greinwald R;
    Aliment Pharmacol Ther; 2006 Jan; 23(2):303-12. PubMed ID: 16393311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of ulcerative proctitis.
    Regueiro MD
    J Clin Gastroenterol; 2004 Oct; 38(9):733-40. PubMed ID: 15365396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with disease evolution in Greek patients with inflammatory bowel disease.
    Chatzicostas C; Roussomoustakaki M; Potamianos S; Paspatis G; Mouzas I; Romanos J; Mavrogeni H; Kouroumalis E
    BMC Gastroenterol; 2006 Jul; 6():21. PubMed ID: 16869971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer pharmacologic agents for the therapy of inflammatory bowel disease.
    Ruderman WB
    Med Clin North Am; 1990 Jan; 74(1):133-53. PubMed ID: 2404172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression.
    Ayres RC; Gillen CD; Walmsley RS; Allan RN
    Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):555-8. PubMed ID: 8823569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study.
    Kono T; Nomura M; Kasai S; Kohgo Y
    Am J Gastroenterol; 2001 Mar; 96(3):793-7. PubMed ID: 11280553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ulcerative colitis and proctosigmoiditis treated locally with hydrocortisone].
    FISCHERMANN K; ZACHARIAE F
    Ugeskr Laeger; 1962 Oct; 124():1580-3. PubMed ID: 13963047
    [No Abstract]   [Full Text] [Related]  

  • 20. Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease.
    Indaram AV; Visvalingam V; Locke M; Bank S
    Am J Gastroenterol; 2000 May; 95(5):1221-5. PubMed ID: 10811331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.